Keyphrases
Metabolism
100%
Rosiglitazone
100%
Depletion Method
100%
Substrate Depletion
100%
Human Liver Microsomes
100%
CYP2C9
57%
CYP2C8
42%
Cytochrome P450 3A4 (CYP3A4)
42%
Drug Interactions
28%
Cytochrome P450 Enzymes
28%
Metabolic Pathway
14%
Therapeutic Strategies
14%
Current Therapeutics
14%
Specific Inhibitor
14%
Oxidative Metabolism
14%
Substrate Range
14%
Cytochrome P450 2E1 (CYP2E1)
14%
Enzyme Pathway
14%
Reaction Velocity
14%
Background Removal
14%
Cytochrome P450 2D6 (CYP2D6)
14%
Hepatic Metabolism
14%
Medicine and Dentistry
Rosiglitazone
100%
Liver Microsome
100%
CYP2C9
57%
CYP2C8
42%
CYP3A4
42%
Cytochrome P450
28%
In Vitro
14%
Aerobic Metabolism
14%
CYP2E1
14%
CYP2D6
14%
Pharmacology, Toxicology and Pharmaceutical Science
Rosiglitazone
100%
CYP2C9
57%
CYP2C8
42%
CYP3A4
42%
Cytochrome P450
28%
Elimination
14%
CYP2E1
14%
CYP2D6
14%